Global and China Drugs of Nervous System Industry Professional Market 2017 size, and the segment markets by regions, types, applications and companies

This report splits Drugs of Nervous System by Product Antiparkinsonism drugs, by Product Antimyasthenics, by Product Antiepileptics, by Product Cerebrovascular disease drugs, by Product Sedative-hypnotic drugs. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Drugs of Nervous System industry.

This report focuses on Chinese market, it covers details players regions product type and other details as following:

Key Players
MSD PHARMA (SINGAPORE) PTE. LTD.Italy
Orion Corporation Finland
Gedeon Richter Plc. Hungary
Novartis Farma S.P.A. Italy
Gedeon Richter Plc.Hungary
Janssen Pharmaceutica N.V. Belgium
Sanofi Aventis Deutschland GmbH France
Taiwan Biotech Co.Ltd
GlaxoSmithKline Pharmaceuticals S.A.Poland
Actavis hf. Iceland
UCB Pharma S.A.Belgium
Janssen-Cilag AG Puerto Rico
Bayer Vital GmbH Germany
Roquette Freres France
Bright Future Pharmaceuticals Factory Hongkong
Atlantic Laboratories Corporation, Ltd. Thailand
KYOWA HAKKO BIO CO.,LTD. Japan

Key Regions

First-tier Cities
Beijing
Shanghai
Guangzhou
Shenzhen

Second-tier Cities
Chengdu
Hangzhou
Wuhan
Tianjin
Nanjing
Chongqing
Xi’an
Qingdao
Shenyang
Dalian
Xiamen
Suzhou
Ningbo
Wuxi

Third-tier Cities
Fourth-tier Cities
Other Regions

Key Product Type

Drugs of Nervous System Market, by Product Category01
L-Dopa
Carbidopa
Benserazide
Sinemet
Selegiline

Drugs of Nervous System Market, by Product Antimyasthenics
Neostigmine
Neostigmine Methylsulfate
Pyridostigmine Bromide
Galanthamine
Edrophonium Chloride

Drugs of Nervous System Market, by Product Antiepileptics
Phenytoin Sodium
Carbamazepine
Phenobarbital
Primidone
Ethosuximide

Drugs of Nervous System Market, by Product Cerebrovascular disease drugs
Nimodipine
Carfergot
Mannitol
Acetazolamide
Piracetam

Drugs of Nervous System Market, by Product Sedative-hypnotic drugs
Diazepam
Chlordiazepoxide
Oxazepam
Nitrazepam
Flunitrazepam

Key Consumers (End User)

Drugs of Nervous System Market, by Consumer
Pharmacy
Hospital
Department of psychiatry
Department of Encephalopathy
Department of neurology

Click Here Download Sample Report Copy from: http://globalqyresearch.com/download-sample/246747

Table of Contents

Chapter One Drugs of Nervous System Market Overview
1.1 China Drugs of Nervous System Market Sales Volume Revenue and Price 2012-2022
1.2 Drugs of Nervous System, by Product Antiparkinsonism drugs2012-2022
1.2.1 China Drugs of Nervous System Sales Market Share by Product Antiparkinsonism drugs2012-2022
1.2.2 China Drugs of Nervous System Revenue Market Share by Product Antiparkinsonism drugs2012-2022
1.2.3 China Drugs of Nervous System Price by Product Antiparkinsonism drugs2012-2022
1.2.4 L-Dopa
1.2.5 Carbidopa
1.2.6 Benserazide
1.2.7 Sinemet
1.2.8 Selegiline
1.2.9 Amantadine
1.2.10 Bromocriptine
1.2.11 Pergolide
1.2.12 Artane
1.3 Drugs of Nervous System, by Product Antimyasthenics 2012-2022
1.3.1 China Drugs of Nervous System Sales Market Share by Product Antimyasthenics 2012-2022
1.3.2 China Drugs of Nervous System Revenue Market Share by Product Antimyasthenics 2012-2022
1.3.3 China Drugs of Nervous System Price by Product Antimyasthenics 2012-2022
1.3.4 Neostigmine
1.3.5 Neostigmine Methylsulfate
1.3.6 Pyridostigmine Bromide
1.3.7 Galanthamine
1.3.8 Edrophonium Chloride
1.4 Drugs of Nervous System, by Product Antiepileptics 2012-2022
1.4.1 China Drugs of Nervous System Sales Market Share by Product Antiepileptics 2012-2022
1.4.2 China Drugs of Nervous System Revenue Market Share by Product Antiepileptics 2012-2022
1.4.3 China Drugs of Nervous System Price by Product Antiepileptics 2012-2022
1.4.4 Phenytoin Sodium
1.4.5 Carbamazepine
1.4.6 Phenobarbital
1.4.7 Primidone
1.4.8 Ethosuximide
1.4.9 Sodium valproate
1.4.10 Clonazepam
1.4.11 Trimethadione
1.4.12 Lamotrigine
1.4.13 Sultiame
1.4.14 Felbamate
1.4.15 Levetiracetam
1.4.16 Topamax
1.5 Drugs of Nervous System, by Product Cerebrovascular disease drugs 2012-2022
1.5.1 China Drugs of Nervous System Sales Market Share by Product Cerebrovascular disease drugs 2012-2022
1.5.2 China Drugs of Nervous System Revenue Market Share by Product Cerebrovascular disease drugs 2012-2022
1.5.3 China Drugs of Nervous System Price by Product Cerebrovascular disease drugs 2012-2022
1.5.4 Nimodipine
1.5.5 Carfergot
1.5.6 Mannitol
1.5.7 Acetazolamide
1.5.8 Piracetam
1.6 Drugs of Nervous System, by Product Sedative-hypnotic drugs 2012-2022
1.6.1 China Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
1.6.2 China Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
1.6.3 China Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
1.6.4 Diazepam
1.6.5 Chlordiazepoxide
1.6.6 Oxazepam
1.6.7 Nitrazepam
1.6.8 Flunitrazepam
1.6.9 Estazolam
1.6.10 Lorazepam
1.6.11 Meprobamate
1.6.12 Hydroxyzine
1.6.13 Captodiamine
1.6.14 Piperilate
1.6.15 Chlormezanone
1.6.16 Trimetozine
1.6.17 Oryzanol
1.6.18 Benzoctamine
1.6.19 Gastrodine
1.6.20 Glutethimide
1.7 Drugs of Nervous System, by Product Sedative-hypnotic drugs 2012-20221.6 Drugs of Nervous System, by Product Others 2012-2022
1.7.1 Global Drugs of Nervous System Sales Market Share by Product Sedative-hypnotic drugs 2012-2022
1.7.2 Global Drugs of Nervous System Revenue Market Share by Product Sedative-hypnotic drugs 2012-2022
1.7.3 Global Drugs of Nervous System Price by Product Sedative-hypnotic drugs 2012-2022
1.7. 4 Diazepam
1.7. 5 Citicoline
1.7.6 Nikethamide
1.7. 7 Lobeline
1.7. 8 Piracetam
1.7. 9 Ligustrazine
1.7.10 Flunarizine
1.7.11 Cerebroprotein Hydrolysate
1.7.12 Sodium Aescinate
1.7.13 Troxerutin
Chapter Two, Drugs of Nervous System by Regions 2012-2022
2.1 China Drugs of Nervous System Sales Market Share by Regions 2012-2022
2.2 China Drugs of Nervous System Revenue Market Share by Regions 2012-2022
2.3 China Drugs of Nervous System Price by Regions 2012-2022
2.4 First-tier Cities
2.4.1 Beijing
2.4.2 Shanghai
2.4.3 Guangzhou
2.4.4 Shenzhen
2.5 Second-tier Cities
2.5.1 Chengdu
2.5.2 Hangzhou
2.5.3 Wuhan
2.5.4 Tianjin
2.5.5 Nanjing
2.5.2 Chongqing
2.5.6 Xi’an
2.5.7 Qingdao
2.5.8 Shenyang
2.5.9 Dalian
2.5.10 Xiamen
2.5.11 Suzhou
2.5.12 Ningbo
2.5.13 Wuxi
2.6 Third-tier Cities
2.7 Fourth-tier Cities
2.8 Other Regions
Chapter Three, Drugs of Nervous System by Brands 2012-2022
3.1 China Drugs of Nervous System Sales Volume Market Share by Brands 2012-2022
3.2 China Drugs of Nervous System Revenue Share by Brands 2012-2022
3.3 China Top Brands Drugs of Nervous System Key Product Model and Market Performance
3.4 China Top Brands Drugs of Nervous System Key Target Consumers and Market Performance
Chapter Four, Drugs of Nervous System by Consumer 2012-2022
4.1 China Drugs of Nervous System Sales Market Share by Consumer 2012-2022
4.2 Pharmacy
4.3 Hospital
4.4 Department of psychiatry
4.5 Department of Encephalopathy
4.6 Department of neurology
4.7 Consuming Habit and Preference
Chapter Five, Top Brands Profile
5.1 MSD PHARMA (SINGAPORE) PTE. LTD.Italy
5.1.1 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Company Details and Competitors
5.1.2 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Key Drugs of Nervous System Models and Performance
5.1.3 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Business SWOT Analysis and Forecast
5.1.4 MSD PHARMA (SINGAPORE) PTE. LTD.Italy Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.2 Orion Corporation Finland
5.2.1 Orion Corporation Finland Company Details and Competitors
5.2.2 Orion Corporation Finland Key Drugs of Nervous System Models and Performance
5.2.3 Orion Corporation Finland Drugs of Nervous System Business SWOT Analysis and Forecast
5.2.4 Orion Corporation Finland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.3 Gedeon Richter Plc. Hungary
5.3.1 Gedeon Richter Plc. Hungary Company Details and Competitors
5.3.2 Gedeon Richter Plc. Hungary Key Drugs of Nervous System Models and Performance
5.3.3 Gedeon Richter Plc. Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
5.3.4 Gedeon Richter Plc. Hungary Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.4 Novartis Farma S.P.A. Italy
5.4.1 Novartis Farma S.P.A. Italy Company Details and Competitors
5.4.2 Novartis Farma S.P.A. Italy Key Drugs of Nervous System Models and Performance
5.4.3 Novartis Farma S.P.A. Italy Drugs of Nervous System Business SWOT Analysis and Forecast
5.4.4 Novartis Farma S.P.A. Italy Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.5 Gedeon Richter Plc.Hungary
5.5.1 Gedeon Richter Plc.Hungary Company Details and Competitors
5.5.2 Gedeon Richter Plc.Hungary Key Drugs of Nervous System Models and Performance
5.5.3 Gedeon Richter Plc.Hungary Drugs of Nervous System Business SWOT Analysis and Forecast
5.5.4 Gedeon Richter Plc.Hungary Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.6 Janssen Pharmaceutica N.V. Belgium
5.6.1 Janssen Pharmaceutica N.V. Belgium Company Details and Competitors
5.6.2 Janssen Pharmaceutica N.V. Belgium Key Drugs of Nervous System Models and Performance
5.6.3 Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
5.6.4 Janssen Pharmaceutica N.V. Belgium Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.7 Sanofi Aventis Deutschland GmbH France
5.7.1 Sanofi Aventis Deutschland GmbH France Company Details and Competitors
5.7.2 Sanofi Aventis Deutschland GmbH France Key Drugs of Nervous System Models and Performance
5.7.3 Sanofi Aventis Deutschland GmbH France Drugs of Nervous System Business SWOT Analysis and Forecast
5.7.4 Sanofi Aventis Deutschland GmbH France Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.8 Taiwan Biotech Co.Ltd
5.8.1 Taiwan Biotech Co.Ltd Company Details and Competitors
5.8.2 Taiwan Biotech Co.Ltd Key Drugs of Nervous System Models and Performance
5.8.3 Taiwan Biotech Co.Ltd Drugs of Nervous System Business SWOT Analysis and Forecast
5.8.4 Taiwan Biotech Co.Ltd Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.9 GlaxoSmithKline Pharmaceuticals S.A.Poland
5.9.1 GlaxoSmithKline Pharmaceuticals S.A.Poland Company Details and Competitors
5.9.2 GlaxoSmithKline Pharmaceuticals S.A.Poland Key Drugs of Nervous System Models and Performance
5.9.3 GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Business SWOT Analysis and Forecast
5.9.4 GlaxoSmithKline Pharmaceuticals S.A.Poland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.10 Actavis hf. Iceland
5.10.1 Actavis hf. Iceland Company Details and Competitors
5.10.2 Actavis hf. Iceland Key Drugs of Nervous System Models and Performance
5.10.3 Actavis hf. Iceland Drugs of Nervous System Business SWOT Analysis and Forecast
5.10.4 Actavis hf. Iceland Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.11 UCB Pharma S.A.Belgium
5.11.1 UCB Pharma S.A.Belgium Company Details and Competitors
5.11.2 UCB Pharma S.A.Belgium Key Drugs of Nervous System Models and Performance
5.11.3 UCB Pharma S.A.Belgium Drugs of Nervous System Business SWOT Analysis and Forecast
5.11.4 UCB Pharma S.A.Belgium Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.12 Janssen-Cilag AG Puerto Rico
5.12.1 Janssen-Cilag AG Puerto Rico Company Details and Competitors
5.12.2 Janssen-Cilag AG Puerto Rico Key Drugs of Nervous System Models and Performance
5.12.3 Janssen-Cilag AG Puerto Rico Drugs of Nervous System Business SWOT Analysis and Forecast
5.12.4 Janssen-Cilag AG Puerto Rico Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.13 Bayer Vital GmbH Germany
5.13.1 Bayer Vital GmbH Germany Company Details and Competitors
5.13.2 Bayer Vital GmbH Germany Key Drugs of Nervous System Models and Performance
5.13.3 Bayer Vital GmbH Germany Drugs of Nervous System Business SWOT Analysis and Forecast
5.13.4 Bayer Vital GmbH Germany Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.14 Roquette Freres France
5.14.1 Roquette Freres France Company Details and Competitors
5.14.2 Roquette Freres France Key Drugs of Nervous System Models and Performance
5.14.3 Roquette Freres France Drugs of Nervous System Business SWOT Analysis and Forecast
5.14.4 Roquette Freres France Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.15 Bright Future Pharmaceuticals Factory Hongkong
5.15.1 Bright Future Pharmaceuticals Factory Hongkong Company Details and Competitors
5.15.2 Bright Future Pharmaceuticals Factory Hongkong Key Drugs of Nervous System Models and Performance
5.15.3 Bright Future Pharmaceuticals Factory Hongkong Drugs of Nervous System Business SWOT Analysis and Forecast
5.15.4 Bright Future Pharmaceuticals Factory Hongkong Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.16 Atlantic Laboratories Corporation, Ltd. Thailand
5.16.1 Atlantic Laboratories Corporation, Ltd. Thailand Company Details and Competitors
5.16.2 Atlantic Laboratories Corporation, Ltd. Thailand Key Drugs of Nervous System Models and Performance
5.16.3 Atlantic Laboratories Corporation, Ltd. Thailand Drugs of Nervous System Business SWOT Analysis and Forecast
5.16.4 Atlantic Laboratories Corporation, Ltd. Thailand Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
5.17 KYOWA HAKKO BIO CO.,LTD. Japan
5.17.1 KYOWA HAKKO BIO CO.,LTD. Japan Company Details and Competitors
5.17.2 KYOWA HAKKO BIO CO.,LTD. Japan Key Drugs of Nervous System Models and Performance
5.17.3 KYOWA HAKKO BIO CO.,LTD. Japan Drugs of Nervous System Business SWOT Analysis and Forecast
5.17.4 KYOWA HAKKO BIO CO.,LTD. Japan Drugs of Nervous System Sales Volume Revenue Price Cost and Gross Margin
Chapter Six, Industry Chain and Supply Chain
6.1 Drugs of Nervous System Industry Chain Structure
6.1.1 R&D
6.1.2 Raw Materials (Components)
6.1.3 Manufacturing Plants
6.1.4 Regional Trading (Import Export and Local Sales)
6.1.5 Online Sales Channel
6.1.6 Offline Channel
6.1.7 End Users
6.2 Drugs of Nervous System Manufacturing
6.2.1 Key Components
6.2.2 Assembly Manufacturing
6.3 Consumer Preference
6.4 Behavioral Habits
6.5 Marketing Environment
Chapter Seven, Development Trend and Research Conclusion
7.1 Development Trend
7.2 Research Conclusion
Methodology and Data Source
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer

Buy This Report from Here: http://globalqyresearch.com/checkout-form/0/246747

About Us

Global QYResearch (http://globalqyresearch.com/) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit 1, 26 Cleveland Road, South Woodford, London,

E182AN, United Kingdom

Call: +44 20 3239 2407

sales@globalqyresearch.com

Linkedin: https://www.linkedin.com/company/global-qy-research

Twitter: http://twitter.com/gqyresearch

Designed by CyFocus.com
Powered by CyFocus.net